Literature DB >> 19597822

The role of arterial stimulation and simultaneous venous sampling in addition to cross-sectional imaging for localisation of biochemically proven insulinoma.

D L Morganstein1, D H Lewis, J Jackson, A Isla, J Lynn, D Devendra, K Meeran, J F Todd.   

Abstract

Insulinomas, although rare, cause considerable morbidity but are frequently amenable to surgical cure. Laparoscopic surgery can now be considered if the tumour is localised pre-operatively, but the optimal imaging approach has not been determined. The objective of this study was to evaluate the ability of different imaging investigations, including CT, MRI, endoscopic ultrasound, octreotide scintigraphy and arterial stimulation with simultaneous venous sampling (ASVS), to localise insulinomas. All patients with biochemically proven insulinoma at our institution underwent ASVS along with other imaging investigations as part of their routine investigation. The results of these investigations were compared with histological findings. Twenty-eight patients with biochemically proven insulinoma confirmed by histology were identified. Ultimately ASVS localised a lesion in all patients. Seventeen patients (61%) had laparoscopic surgery. Tumor-detection rates for other imaging investigations included 43.5% of cases using CT, 71% using MRI, 86% using endoscopic ultrasound and 33% using octreotide scintigraphy. In four patients, the ASVS was the only test to correctly localise the lesion. ASVS should be considered routinely before surgery to ensure accurate localisation of insulinomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597822     DOI: 10.1007/s00330-009-1444-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  20 in total

1.  The frequency of gastrointestinal endocrine tumours in a well-defined population--Northern Ireland 1970-1985.

Authors:  R G Watson; C F Johnston; M M O'Hare; J R Anderson; B G Wilson; J S Collins; J M Sloan; K D Buchanan
Journal:  Q J Med       Date:  1989-07

2.  Modified intra-arterial calcium stimulation with venous sampling test for preoperative localization of insulinomas.

Authors:  L Defreyne; K König; M M Lerch; U J Hesse; R Rottiers; G Feifel; B de Hemptinne; B Kramann; M Kunnen
Journal:  Abdom Imaging       Date:  1998 May-Jun

Review 3.  Nuclear medicine in the detection and management of pancreatic islet-cell tumours.

Authors:  Irene Virgolini; Tatjana Traub-Weidinger; Clemens Decristoforo
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2005-06       Impact factor: 4.690

4.  Insulinoma and islet cell hyperplasia: value of the calcium intraarterial stimulation test when findings of other preoperative studies are negative.

Authors:  P L Pereira; A J Roche; G W Maier; P E Huppert; F Dammann; C T Farnsworth; S H Duda; C D Claussen
Journal:  Radiology       Date:  1998-03       Impact factor: 11.105

Review 5.  Laparoscopic pancreatic surgery for islet cell tumors of the pancreas.

Authors:  Ahmad Assalia; Michel Gagner
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

6.  Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium.

Authors:  J L Doppman; R Chang; D L Fraker; J A Norton; H R Alexander; D L Miller; E Collier; M C Skarulis; P Gorden
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

7.  CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas.

Authors:  Hervé Gouya; Olivier Vignaux; Joelle Augui; Bertrand Dousset; Laurent Palazzo; André Louvel; Stanislas Chaussade; Paul Legmann
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

Review 8.  Multi-detector row CT of pancreatic islet cell tumors.

Authors:  Karen M Horton; Ralph H Hruban; Charles Yeo; Elliot K Fishman
Journal:  Radiographics       Date:  2006 Mar-Apr       Impact factor: 5.333

9.  Pancreatic insulinomas: diagnosis and surgical treatment of 74 patients.

Authors:  Xi Chen; Wei-Yao Cai; Wei-Ping Yang; Hong-Wei Li
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2002-08

10.  Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience.

Authors:  Jean-Marc Guettier; Anthony Kam; Richard Chang; Monica C Skarulis; Craig Cochran; H Richard Alexander; Steven K Libutti; James F Pingpank; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

View more
  12 in total

1.  Selective Arterial Calcium Stimulation With Hepatic Venous Sampling Differentiates Insulinoma From Nesidioblastosis.

Authors:  Scott M Thompson; Adrian Vella; Geoffrey B Thompson; Kandelaria M Rumilla; F John Service; Clive S Grant; James C Andrews
Journal:  J Clin Endocrinol Metab       Date:  2015-08-27       Impact factor: 5.958

Review 2.  Is endoscopic ultrasonography more sensitive than magnetic resonance imaging in detecting and localizing pancreatic neuroendocrine tumors?

Authors:  Peter Herbert Kann
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 3.  Pancreatic neuroendocrine tumors.

Authors:  Shailesh V Shrikhande; Bhawna Sirohi; Mahesh Goel; Savio G Barreto
Journal:  Indian J Gastroenterol       Date:  2012-10-03

4.  Intra-arterial calcium stimulation test with hepatic venous sampling for preoperative diagnosis of a large insulinoma in an obese young man.

Authors:  Ya-Cheng Chen; Chang-Hsien Liu; Chih-Yung Yu; Guo-Shu Huang
Journal:  Singapore Med J       Date:  2014-08       Impact factor: 1.858

5.  Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys40(AhxHYNIC-[99mTc]/EDDA)NH2]-Exendin-4 over Conventional Imaging Modalities for Localization of Insulinoma.

Authors:  Katra Senica; Ales Tomazic; Ales Skvarca; Petra Kolenc Peitl; Renata Mikolajczak; Alicja Hubalewska-Dydejczyk; Luka Lezaic
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

6.  Preoperative localization of an insulinoma: selective arterial calcium stimulation test performance.

Authors:  J Morera; A Guillaume; P Courtheoux; L Palazzo; A Rod; M Joubert; Y Reznik
Journal:  J Endocrinol Invest       Date:  2015-11-17       Impact factor: 4.256

Review 7.  Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  J Gastroenterol       Date:  2012-08-11       Impact factor: 7.527

8.  ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

Authors:  M Falconi; B Eriksson; G Kaltsas; D K Bartsch; J Capdevila; M Caplin; B Kos-Kudla; D Kwekkeboom; G Rindi; G Klöppel; N Reed; R Kianmanesh; R T Jensen
Journal:  Neuroendocrinology       Date:  2016-01-05       Impact factor: 4.914

9.  ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.

Authors:  Robert T Jensen; Guillaume Cadiot; Maria L Brandi; Wouter W de Herder; Gregory Kaltsas; Paul Komminoth; Jean-Yves Scoazec; Ramon Salazar; Alain Sauvanet; Reza Kianmanesh
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

10.  Should the Selective Arterial Secretagogue Injection Test for Insulinoma Localization Be Evaluated at 60 or 120 Seconds?

Authors:  Keijiro Ueda; Tetsuhide Ito; Ken Kawabe; Lingaku Lee; Takashi Fujiyama; Yuichi Tachibana; Masami Miki; Kohei Yasunaga; Takehiro Takaoka; Akihiro Nishie; Yoshiki Asayama; Robert T Jensen; Yoshihiro Ogawa
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.